Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy
NCT03279900 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101
Last updated 2018-09-19
Summary
This study use an observational study design from patient medical records to obtain data on patient demographics, nutritional status, 6MP dosing, and albumin levels of LLA child patients.
Conditions
Sponsors & Collaborators
-
Indonesia University
lead OTHER
Principal Investigators
-
Rianto Setiabudy, Professor · Departemen of Pharmacology and therapeutics, FMUI
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-02
- Primary Completion
- 2018-05-16
- Completion
- 2018-07-16
Countries
- Indonesia
Study Locations
More Related Trials
-
Targeted High Throughput Sequencing in the Diagnosis of Pediatric Acute Leukemia
NCT01991249 ·Status: COMPLETED ·Phase: NA
-
Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
NCT03035344 ·Status: UNKNOWN
-
Dependence Receptors and Leukemia
NCT03278145 ·Status: UNKNOWN
-
Home Away From Home - Medical Outcomes
NCT02774850 ·Status: COMPLETED
-
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
NCT00002499 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)
NCT00131053 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired Protocol
NCT04677231 ·Status: UNKNOWN
-
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
NCT01503632 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL
NCT02046694 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol
NCT03022747 ·Status: UNKNOWN ·Phase: PHASE2
-
ObServatory Children Acute RElated Therapy Leukemia
NCT04450784 ·Status: UNKNOWN
-
Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia
NCT02344966 ·Status: UNKNOWN
-
Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children.
NCT02862652 ·Status: COMPLETED ·Phase: NA
-
Home Away From Home - Quality of Life Surveys
NCT02777021 ·Status: COMPLETED
-
Outcomes of Acute Myeloid Leukemia Patients
NCT04392310 ·Status: UNKNOWN
-
Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
NCT00764907 ·Status: UNKNOWN ·Phase: PHASE3
-
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024 ·Status: RECRUITING
-
ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia
NCT00114348 ·Status: COMPLETED ·Phase: PHASE4
-
Anti-mullerian Hormone in Acute Lymphoblastic Leukemia
NCT05793463 ·Status: UNKNOWN
-
Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia
NCT01245231 ·Status: COMPLETED
-
Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients
NCT02042690 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Analysis of High Dose Methotrexate in Pediatric Lymphoblastic Malignancies
NCT02011022 ·Status: COMPLETED ·Phase: NA
-
RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL
NCT05127148 ·Status: RECRUITING
-
Coagulopathy in Childhood Acute Lymphoblastic Leukaemia
NCT06242353 ·Status: NOT_YET_RECRUITING
-
Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia
NCT05639673 ·Status: RECRUITING